Tánaiste and then foreign minister Simon Harris assured pharma companies that the Government had their back, both in facing ...

Propelled by a flurry of dealmaking late in the year, 2025 M&A ended on a strong note, with high activity expected to ...

Alpelisib plus fulvestrant significantly improved PFS in PIK3CA-mutated, HR-positive, HER2-negative advanced breast cancer, achieving a median PFS of 7.4 months versus 2.8 months with placebo. The ...

A tumor-informed ctDNA assay identified MRD in TNBC patients, indicating a 30-fold higher risk of distant recurrence for MRD-positive individuals. The NSABP B-59/GBG 96-GeparDouze trial involved 1550 ...

The agenda for the 25 (th) annual Bio-IT World Conference & Expo highlights the latest advancements in agentic AI, generative AI, federated learning, foundation models, robotics, multimodal data ...

Younger donor age (18-35) is crucial for stem cell transplant success and patient survival; superseding related sibling matches and older donor paradigms.

Outgoing GSK boss Dame Emma Walmsley has said the US is the best place to invest, in the latest blow to Britain’s pharmaceutical sector, after a raft of drugs firms have scrapped or paused plans to ...

The March 10 Damascus-SDF agreement remains stalled amid Kurdish demands for decentralization and inclusion, with analysts ...

Detailed price information for Tempramed Technologies Ltd. (VIVI-CN) from The Globe and Mail including charting and trades.

Title: Phase 1/2 study of spevatamig (PT886) in combination with gemcitabine plus nab-paclitaxel (GnP) in frontline (1L) treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC) Session: ...

A full-time Rapido/Uber rider in Hyderabad, covering 120-150 km daily, says the city’s traffic crisis results from many large cars carrying one person, easy car EMIs, narrow old roads and weak public ...

Italian pharmaceutical company Cosmo Pharmaceuticals recently announced that its newly developed male-pattern hair loss ...